pdufa.bio
HomeDecisions › EBS 2026-02-13

EBS FDA decision — Feb 13, 2026

✓ APPROVED

Emergent BioSolutions Inc. — OTC NARCAN Nasal Spray w/ carrying case · Opioid overdose.

Run-up into the decision (T-120 → T+5)

PDUFA 2/13/26$13.9$7.568/29/25
Daily close, T-120 (8/29/25) through T+5. Run-up high $13.9 on 1/8/26, low $7.56 on 9/12/25 (T-120 to T-1). FDA decision 2/13/26. Historical price action, not a forecast.

Key facts

FDA decision date2026-02-13
OutcomeApproved
Drug / candidateOTC NARCAN Nasal Spray w/ carrying case
CompanyEmergent BioSolutions Inc.
120-day run-up (T-120→T-1)+17.6%